The role of HIV infection and drug and alcohol dependence in hospital mortality among critically ill patients

Journal of Critical Care

Volumn 23, Issue 3, 2008, Pages 275-280

  Palepu, A ^a,b,c,g   Khan, N A ^a,b,c,g   Norena, M ^a   Wong, H ^c,f,g   Chittock, D R ^e,g   Dodek, P M ^a,c,d,g  

^a ST PAUL S HOSPITAL   (Canada)

^b Division of Internal Medicine   (Italy)

^c Department of Medicine ^*

^d Division of Critical Care Medicine

^e VANCOUVER GENERAL HOSPITAL   (Canada)

^f HIV Clinical Trials Network

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Critical illness; HIV; Hospital mortality; Logistic regression; Pneumonia; Sepsis; Substance abuse

Indexed keywords

ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION II SCORE; ADULT; AGE; ALCOHOLISM; ARTICLE; CONFIDENCE INTERVAL; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DRUG DEPENDENCE; DRUG OVERDOSE; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PNEUMONIA; PROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SEX DIFFERENCE; SOCIOECONOMICS;

ADULT; AGE FACTORS; ALCOHOLISM; APACHE; CRITICAL ILLNESS; FEMALE; HIV INFECTIONS; HOSPITAL MORTALITY; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; OVERDOSE; PNEUMONIA; PROSPECTIVE STUDIES; SEPSIS; SEX FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 49949116084     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2007.04.001     Document Type: Article

References (36)

1. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Drug Abuse Warning Network, 2003: Interim National Estimates of Drug-Related Emergency Department Visits. DAWN Series D-26, DHHS Publication No. (SMA) 04-3972 (2004) Rockville, MD
2. Palepu A., Tyndall M.W., Leon H., Muller J., O'Shaughnessy M.V., Schechter M.T., et al. Hospital utilization and costs in a cohort of injection drug users. CMAJ 165 (2001) 415-420
3. Single E., Rehm J., Robson L., and Truong M.V. The relative risks and etiologic fractions of different causes of death and disease attributable to alcohol, tobacco and illicit drug use in Canada. CMAJ 162 (2000) 1669-1675
4. Single E., Robson L., Rehm J., and Xie X. Morbidity and mortality attributable to alcohol, tobacco, and illicit drug use in Canada. Am J Public Health 89 (1999) 385-390
5. Mokhlesi B., Garimella P.S., Joffe A., and Velho V. Street drug abuse leading to critical illness. Intensive Care Med 30 (2004) 1526-1536
6. Wilson K.C., and Saukkonen J.J. Acute respiratory failure from abused substances. J Intensive Care Med 19 (2004) 183-193
7. Morris A., Creasman J., Turner J., Luce J.M., Wachter R.M., and Huang L. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 166 (2002) 262-267
8. Nickas G., and Wachter R.M. Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med 160 (2000) 541-547
9. Nuesch R., Geigy N., Schaedler E., and Battegay M. Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients. Eur J Clin Microbiol Infect Dis 21 (2002) 684-687
10. Narasimhan M., Posner A.J., DePalo V.A., Mayo P.H., and Rosen M.J. Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest 125 (2004) 1800-1804
11. Casalino E., Wolff M., Ravaud P., Choquet C., Bruneel F., and Regnier B. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 18 (2004) 1429-1433
12. Strathdee S.A., Patrick D.M., Currie S.L., Cornelisse P.G., Rekart M.L., Montaner J.S., et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 11 (1997) F59-F65
13. Hogg R., Heath K., Yip B., Craib K., O'Shaughnessy M., Schechter M., et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 279 (1998) 450-454
14. Hogg R.S., Yip B., Kully C., Craib K.J., O'Shaughnessy M.V., Schechter M.T., et al. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ 160 (1999) 659-665
15. Palella Jr. F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 (1998) 853-860
16. Miller R.F., Allen E., Copas A., Singer M., and Edwards S.G. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax 61 (2006) 716-721
17. Huang L., Quartin A., Jones D., and Havlir D.V. Intensive care of patients with HIV infection. N Engl J Med 355 (2006) 173-181
18. Strathdee S.A., Palepu A., Cornelisse P.G., Yip B., O'Shaughnessy M.V., Montaner J.S., et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 280 (1998) 547-549
19. Palepu A., Horton N.J., Tibbetts N., Meli S., and Samet J.H. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction 99 (2004) 361-368
20. Celentano D.D., Vlahov D., Cohn S., Shadle V.M., Obasanjo O., and Moore R.D. Self-reported antiretroviral therapy in injection drug users. JAMA 280 (1998) 544-546
21. Celentano D.D., Galai N., Sethi A.K., Shah N.G., Strathdee S.A., Vlahov D., et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 15 (2001) 1707-1715
22. Lucas G.M., Gebo K.A., Chaisson R.E., and Moore R.D. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 16 (2002) 767-774
23. Lucas G.M., Cheever L.W., Chaisson R.E., and Moore R.D. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr 27 (2001) 251-259
24. Raine R., Goldfrad C., Rowan K., and Black N. Influence of patient gender on admission to intensive care. J Epidemiol Community Health 56 (2002) 418-423
25. Young J.D., Goldfrad C., and Rowan K. Development and testing of a hierarchical method to code the reason for admission to intensive care units: the ICNARC coding method. Intensive Care National Audit & Research Centre. Br J Anaesth 87 (2001) 543-548
26. de Keizer N.F., Bonsel G.J., Goldfad C., and Rowan K.M. The added value that increasing levels of diagnostic information provide in prognostic models to estimate hospital mortality for adult intensive care patients. Intensive Care Med 26 (2000) 577-584
27. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
28. Hutchings A., Raine R., Brady A., Wildman M., and Rowan K. Socioeconomic status and outcome from intensive care in England and Wales. Med Care 42 (2004) 943-951
29. Morris A., Masur H., and Huang L. Current issues in critical care of the human immunodeficiency virus-infected patient. Crit Care Med 34 (2006) 42-49
30. Norena M., Wong H., Thompson W.D., Keenan S.P., and Dodek P.M. Severity of illness and comorbidity scores as predictors of intensive care outcomes. Journal of Critical Care (2007) [in press]
31. Thompson W., Dodek P.M., Norena M., and Dodek J. Computerized physician order entry of diagnostic tests in an intensive care unit is associated with improved timeliness of service. Crit Care Med 32 (2004) 1306-1309
32. Public Health Agency of Canada. HIV and AIDS in Canada. Surveillance report to June 30, 2006 (2006), Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, Ottawa
33. Alves C., Nicolas J.M., Miro J.M., Torres A., Agusti C., Gonzalez J., et al. Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients. Eur J Respir Dis 17 (2001) 87-93
34. Rosenberg A.L., Seneff M.G., Atiyeh L., Wagner R., Bojanowski L., and Zimmerman J.E. The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: implications for future care in the age of increasing antiretroviral resistance. Crit Care Med 29 (2001) 548-556
35. Dodek P.M. Surviving sepsis: but for how long?. Intensive Care Med 31 (2005) 171-173
36. Afessa B., and Green B. Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU. The PIP (pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study. Chest 118 (2000) 138-145